Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with schizophrenia, according ...
Nov 19, 2024
1
0
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.
Nov 15, 2024
0
2
Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, according to a new study from researchers at ICES, The Ottawa Hospital, University of Ottawa's Department ...
Nov 13, 2024
0
43
Scientists have known for decades that the classic symptoms of schizophrenia, such as jumping to conclusions or difficulty adjusting to new information, can be attributed to poor communication between the cerebral cortex ...
Nov 7, 2024
0
39
A research team has explored the agreement or discrepancy between subjective social cognitive difficulties and actual cognitive impairment. Their study aimed to identify clinical subtypes in patients with schizophrenia, and ...
Oct 29, 2024
0
0
A collaborative study between researchers at the Icahn School of Medicine at Mount Sinai and Harvard Medical School has identified genetic mutations that occur during brain development and may contribute to the development ...
Oct 11, 2024
0
62
Auditory hallucinations are likely the result of abnormalities in two brain processes: a "broken" corollary discharge that fails to suppress self-generated sounds, and a "noisy" efference copy that makes the brain hear these ...
Oct 3, 2024
0
178
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.
Sep 28, 2024
0
55
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and. Drug Administration.
Sep 27, 2024
0
3
New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally adequate ...
Sep 23, 2024
0
11
